BioGenixMD products are designed with specific clinical intentions and outcomes regarding their effects. We invest significant time, money, and resources into developing safe, effective products. Below is an overview of our rigorous research process:
AMP-Activated Protein Kinase (AMPK)
Every product undergoes in-house testing followed by beta testing to ensure product effectiveness.
Upon formula approval, a Clinical White Paper is developed to support the product design and function based on peer-reviewed scientific journals.
We produce small batches of approved formulas to conduct preclinical studies and validate results internally.
We outsource to third-party clinical studies to validate and substantiate all product claims.
Once formulas are validated, products undergo third-party testing for quality and purity. Explore our research support below: